Olivier Elemento, Director of Englander Institute for Precision Medicine, shared a post on LinkedIn:
“A great pleasure to host Dr. Parsa Mirhaji from NYU’s Perlmutter Cancer Center together with his colleague Adil Ahmed at the Englander Institute for Precision Medicine today. They are doing truly impressive work on using LLMs for patient screening and clinical trials matching, with a particular strong focus on implementation and continuous validation.Getting this kind of in-house trial matching right is a huge win for patients and for internal clinical research programs.
Their progress serves as a superb model for other academic medical centers.
Thank you Parsa and Adil for sharing your valuable work with our team !”
More posts featuring Olivier Elemento on OncoDaily.